Deletion of Sangamo BioSciences

Comment: copy/pasted promo; clear |COI
Stance: delete
Cited policy: Wikipedia:Conflict of interest (WP:COI)

Comment: for lack of available sources confirming notability - the subject appears to fail  - and for the overly promotional tone (only really a step away from blatant advertising), which given the notability issues doesn't seem like something that could be fixed by a rewrite
Stance: delete
Cited policy: Wikipedia:Notability (WP:CORP)

Comment: or perhaps redirect to Zinc finger nuclease#Prospects. I was unable to find more than brief mentions of the company in reliable sources, so it seems to fail notability thresholds per . Perhaps the most notable thing about the company is their SB-728-T clinical trial, which was discussed in reliable sources like a http://www.nytimes.com/2009/12/29/health/research/29zinc.html New York Times article and a http://www.scientificamerican.com/article/new-aids-treatment-immune-cell-genes/ Scientific American article. These independent RS suggest that a mention of the trial at WP is reasonable and indeed it is already at Zinc finger nuclease#Prospects in the last sentence. I'd be OK with a redirect to that section, but because it isn't a perfect target, delete is a reasonable option too
Stance: delete
Cited policy: Wikipedia:Notability (WP:GNG)